Sensei Biotherapeutics, Inc. - Common Stock (SNSE)
26.25
+17.12 (187.51%)
NASDAQ · Last Trade: Feb 18th, 4:36 PM EST
Detailed Quote
Previous Close
9.130
Open
28.00
Bid
26.00
Ask
26.51
Day's Range
22.07 - 31.94
52 Week Range
5.000 - 18.35
Volume
12,424,532
Market Cap
813.25M
PE Ratio (TTM)
2.969
EPS (TTM)
8.8
Dividend & Yield
N/A (N/A)
1 Month Average Volume
60,075
Chart
About Sensei Biotherapeutics, Inc. - Common Stock (SNSE)
Sensei Biotherapeutics Inc is a biotechnology company focused on developing innovative therapies for cancer and other serious diseases. The company leverages its proprietary platform to create personalized medicine approaches that harness the power of the immune system to target and combat tumors. By utilizing advanced science and technology, Sensei aims to transform the treatment landscape for patients through the development of novel immune-oncology solutions, with a commitment to improving clinical outcomes and enhancing patient quality of life. Read More
Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today announced that it has acquired Faeth Therapeutics Inc. (“Faeth”), a clinical-stage biotechnology company developing multi-node therapies that target tumor metabolism and signaling. The acquisition brings Faeth’s lead asset PIKTOR, a proprietary investigational all-oral combination of serabelisib and sapanisertib that inhibits multiple nodes of the PI3K/AKT/mTOR pathway through PI3K-alpha and dual mTORC1/2 targeting, into Sensei’s pipeline.
PARIS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Egle Therapeutics SAS (Egle), a clinical-stage biotechnology company pioneering precision medicines that modulate regulatory T cells (Tregs) to rebalance immune function in patients with autoimmune diseases and cancer, today announced the appointment of John Celebi, M.B.A., as chief executive officer. Mr. Celebi is a seasoned biotechnology executive with over 30 years of experience building and scaling innovative life sciences companies and has been a member of the Egle board of directors since 2024.
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.
Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
